Urgent high quality communications from across the chemical sciences.
Impact Factor 6.378 100 Issues per Year Indexed in MEDLINE
Communication

Inhibitors of an essential mycobacterial cell wall lipase (Rv3802c) as tuberculosis drug leads

Show Affiliations
Hide Affiliations
*
Corresponding authors
a
Centenary Institute of Cancer Medicine and Cell Biology, Newtown, Australia
b
School of Chemistry, The University of Sydney, Australia
E-mail: richard.payne@sydney.edu.au;
Fax: +61 2 9351 3329 ;
Tel: +61 2 9351 3329
c
Sydney Medical School, The University of Sydney, Australia
Chem. Commun., 2011,47, 5166-5168

DOI: 10.1039/C0CC05635A
Received 16 Dec 2010, Accepted 17 Feb 2011
First published online 07 Mar 2011
| | | | | | More
Please wait while Download options loads
Download Citation
 
 
This may take some time to load.

Supplementary Info